Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters








Year range
1.
Odontol. sanmarquina (Impr.) ; 24(2): 19-27, abr.-jun. 2021.
Article in Spanish, English | LILACS-Express | LILACS | ID: biblio-1178063

ABSTRACT

El granuloma central de células gigantes (GCCG) es una lesión benigna intraósea de los maxilares. Tradicionalmente, la cirugía es el tratamiento más utilizado para este tipo de patología, sin embargo, en los últimos años se ha propuesto el uso de inyecciones intra- lesionales de corticoesteroides como alternativa conservadora. El objetivo de este estudio fue realizar una revisión bibliográfica de los casos tratados con corticoesteroides. Para esto, se utilizó la plataforma de PubMed y Google Scholar para buscar artículos publica- dos entre 1994 y el 2020, relacionados al GCCG y su tratamiento con corticoesteroides. Se encontraron 28 artículos y un resumen con 61 pacientes en total; en la mayoría de los casos se utilizaron inyecciones intralesionales semanales de acetonido de triamcinolona con anestésico durante 6 semanas, aunque se reportaron variantes del protocolo. De los 61 casos, 38 tuvieron una resolución completa y en los demás casos fue necesario realizar tratamiento quirúrgico adicional. Con base en lo anterior, parece que el uso de inyecciones intralesionales de triamcinolona tiene un efecto positivo en el tratamiento del GCCG al permitir una resolución completa de la lesión o una disminución en su tamaño, de manera que la cirugía posterior sea más conservadora.


Central giant cell granuloma (CGCG) is a benign intraosseous lesion of the jaws. Traditionally, surgery is the most used treatment for this type of pathology, however, in recent years the use of intralesional corticosteroids injections has been proposed as a conservative alternative. The aim of this study is to carry out a bibliographic review of the cases treated with corticosteroids. The author used PubMed and Google Scholar platforms were used to search for articles published between 1994 and 2020, related to CGCG and its treatment with corticosteroids. The results of this research were 28 articles and one abstract were found with 61 patients in total; in most cases, weekly intralesional injections of triamcinolone acetonide with anesthetic were used for 6 weeks, although protocol variants were reported. Of the 61 cases, 38 had complete resolution while the other cases required additional surgical treatment. From this, it seems that the use of intralesional triamcinolone injections have a positive effect in the treatment of CGCG by allowing a complete resolution of the lesion or a decrease in its size, so that subsequent surgery is more conservative.

2.
Indian J Dermatol Venereol Leprol ; 2013 Sept-Oct; 79(5): 563-575
Article in English | IMSEAR | ID: sea-148750

ABSTRACT

Alopecia areata (AA) is a common form of non-scarring hair loss of scalp and/or body. Genetic predisposition, autoimmunity, and environmental factors play a major role in the etiopathogenesis of AA. Patchy AA is the most common form. Atopy and autoimmune thyroiditis are most common associated conditions. Peribulbar and intrabulbar lymphocytic infl ammatory infi ltrate resembling “swarm of bees” is characteristic on histopathology. Treatment is mainly focused to contain the disease activity. Corticosteroids are the preferred treatments in form of topical, intralesional, or systemic therapy. Camoufl age in the form of wigs may be an alternative option in refractory cases.


Subject(s)
Adrenal Cortex Hormones/therapeutic use , Alopecia Areata/drug therapy , Alopecia Areata/etiology , Alopecia Areata/physiopathology , Humans , Scalp/pathology
SELECTION OF CITATIONS
SEARCH DETAIL